Compare Nebius Group NV (NBIS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs Health Care Select Sector SPDR Fund — how do they compare? Nebius Group NV trades at $234.6 (market cap $65.34B), while Health Care Select Sector SPDR Fund trades at $167.05. Which is the better fit depends on your goals.
| NBIS | XLV | |
|---|---|---|
Market Cap | $65.34B | — |
Sector | Technology | — |
52-Week High | $286.69 | $175.68 |
52-Week Low | $73.87 | $134.13 |
Enterprise Value | $67.47B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NBIS stock trades at $243.88, up 7.73% on the day, driven by a strategic partnership with Palantir for sovereign AI infrastructure, as reported by Benzinga on September 8, 2026. The stock shows bullish technical signals with strong moving average support and a consensus analyst price target of $300.43. Revenue growth is projected to surge from $530 million in 2025 to $1.4 billion in 2026, though net income margins are thin at 3.13%.
The outlook is positive due to high AI demand and analyst optimism, with 80% buy ratings. Risks include elevated valuation multiples, such as a P/E of 74.61, and execution challenges in scaling infrastructure. Investors should weigh growth potential against profitability concerns and market volatility.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
